Wharton’s Jelly MSCs: Potential Weapon to Sharpen for Our Battle against DM

Dina H Kassem,Mohamed M Kamal

doi:10.1016/j.tem.2020.01.001

Wharton’s Jelly MSCs: Potential Weapon to Sharpen for Our Battle against DM

Dina H Kassem, Mohamed M Kamal

https://doi.org/10.1016/j.tem.2020.01.001

Copy DOI

Journal: Trends in Endocrinology & Metabolism	Publication Date: Feb 5, 2020
Citations: 10

Affiliation: Ain Shams University, British University in Egypt

#Wharton's Jelly Mesenchymal Stem Cells #Wharton's Jelly + Show 8 more

Abstract
Full-Text
Similar Papers

Abstract

Diabetes mellitus (DM) is a devastating metabolic disease. Stem cell therapy provides great hope to all diabetic patients. Umbilical cord (UC) Wharton's jelly mesenchymal stem cells (WJ-MSCs) specifically provides a potential cell therapy for DM. In this article, we discuss major advantages of WJ-MSCs and challenges facing their clinical utility in DM.

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title

Journal

Date

Author

View more papers

More From: Trends in Endocrinology & Metabolism

Paper Title

Journal

Date

Author

View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.